Übersetzung für "Hepatic cirrhosis" in Deutsch

In patients with hepatic cirrhosis the pharmacokinetics of hydrochlorothiazide has not changed significantly.

Severe hepatic impairment, biliary cirrhosis and cholestasis (see section 4.2).

Hepatic fibrosis and cirrhosis of the liver are preferred according to the invention.

High adiponectin levels were determined in patients with hepatic cirrhosis .

These are held responsible for decompensation phenomena in hepatic fibrosis and hepatic cirrhosis.

Each year, about 170,000 people die of complications of hepatic cirrhosis in Europe.

Voriconazole has not been studied in patients with severe chronic hepatic cirrhosis (Child-Pugh C).

Valsartan should not be administered in patients with severe hepatic impairment, cirrhosis or biliary obstruction.

No pharmacokinetic data are available for patients with severe hepatic cirrhosis (Child-Pugh C).

Eventually hepatic necrosis or cirrhosis with liver failure develops.

About 20% of the individuals suffering from chronic hepatitis C show histological signs of hepatic cirrhosis.

Milk thistle is traditionally used in cases of hepatic (cirrhosis, jaundice and hepatitis) and biliary disorders.

The dosage schedule must be adjusted in case of hepatic insufficiency, hepatic cirrhosis, jaundice, and ascites.

It is estimated that up to 0.3 per cent of the general population develops hepatic cirrhosis.

Road traffic accidents, domestic violence, sexual abuse of children, hepatic cancer, liver cirrhosis and foetal damage are just some of the known detriments of alcohol.

Perindopril kinetics are modified in patients with cirrhosis: hepatic clearance of the parent molecule is reduced by half.

Limited data from patients with an active history of chronic hepatic cirrhosis in the Phase 3 studies showed that median plasma levels of fidaxomicin and OP-1118 may be approximately 2- and 3-fold higher, respectively, than in non-cirrhotic patients.

However, because Diovan is eliminated via the biliary route, the CHMP agreed that it should be contraindicated in patients with severe liver diseases and “should not be administered in patients with severe hepatic impairment, cirrhosis or biliary obstruction”.

Perindopril kinetics are modified in patients with cirrhosis : hepatic clearance of the parent molecule is reduced by half.

It is recommended that the standard loading dose regimens be used but that the maintenance dose be halved in patients with mild to moderate hepatic cirrhosis (Child-Pugh A and B) receiving voriconazole (see section 5.2).

Studies with a 1000 mg dose of valaciclovir in adult patients show that dose modification is not required in patients with mild or moderate cirrhosis (hepatic synthetic function maintained).

In cases of moderate hepatic insufficiency (cirrhosis, Child-Pugh Class A or B), the starting dose should be 5 mg and only increased with caution.

In volunteers with mild to moderate hepatic cirrhosis (Child-Pugh A and B) sildenafil clearance was reduced, resulting in increases in AUC (84%) and Cmax (47%) compared to age-matched volunteers with no hepatic impairment.

The CHMP also considered that in view of the fact that Diovan is eliminated via the biliary route, it should be contraindicated in patients with severe liver diseases and “ should not be administered in patients with severe hepatic impairment, cirrhosis or biliary obstruction.